Neurology
Our world-leading immunoglobulin (Ig) franchise includes an intravenous and a subcutaneous option and is the cornerstone for CSL Behring's neurology therapeutic treatments. Our efforts in this area focus on bringing trusted products and technologies to serve patients with a rare and serious neurologic disease: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Additional Resources
PolyNeuroExchange.com
PolyNeuroExchange
GBS-CIDP.org
CIDP Patient Organization
RareDiseases.org
National Organization for Rare Disorders (NORD)